Subhash Kumar
About Subhash Kumar
Data last updated:
Subhash Kumar has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Evitalife Science Private Limited and Evitalife Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Evitalife Pharma Private Limited at ₹5.68 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Evitalife Pharma Private Limited U24233DL2012PTC229963 | Director | 13 Mar 2016 | 2012 | ₹5.68 Cr (FY 2024) | Active |
| Evitalife Science Private Limited U24230HP2021PTC008354 | Director | 11 Feb 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhash Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhash Kumar
Subhash Kumar has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Evitalife Science Private Limited and Evitalife Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Evitalife Pharma Private Limited at ₹5.68 Cr (FY 2024).
Subhash Kumar is associated with 2 companies as Director, including Evitalife Pharma Private Limited (₹5.68 Cr), Evitalife Science Private Limited.
Subhash Kumar has expertise in General Business.
Subhash Kumar has 10 years in corporate governance.
By reported revenue, the largest current company of Subhash Kumar is Evitalife Pharma Private Limited, with revenue of ₹5.68 Cr (FY 2024).
Subhash Kumar currently holds positions at 2 companies: Evitalife Pharma Private Limited (₹5.68 Cr), Evitalife Science Private Limited.